Patents by Inventor Silvia Donnici Garcia

Silvia Donnici Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particle size stabilization process
    Patent number: 10888500
    Abstract: The present invention provides a new process for stabilizing the particle size of micronized glycopyrronium salt (such as glycopyrronium bromide) which yields a micronized product exhibiting improved chemical and polymorphic stability even after prolonged storage. The invention also relates to compositions comprising said stabilized glycopyrronium salt (such as glycopyrronium bromide) and to dry powder inhaler devices and capsules or blisters comprising the stabilized glycopyrronium salt (such as glycopyrronium bromide). The glycopyrronium salt (such as glycopyrronium bromide) or compositions of the invention may be used as a medicament, for instance in the treatment of asthma, chronic obstructive pulmonary disease or cystic fibrosis or related diseases.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: January 12, 2021
    Assignee: INKE, S.A.
    Inventors: Josep Terradas Camins, Josep Maria Carulla Oliver, Silvia Donnici Garcia, David Gomez Lamarca, Maria Jose Martinez Velon, Emma Recio Soler
  • PARTICLE SIZE STABILIZATION PROCESS
    Publication number: 20190175451
    Abstract: The present invention provides a new process for stabilizing the particle size of micronized glycopyrronium salt (such as glycopyrronium bromide) which yields a micronized product exhibiting improved chemical and polymorphic stability even after prolonged storage. The invention also relates to compositions comprising said stabilized glycopyrronium salt (such as glycopyrronium bromide) and to dry powder inhaler devices and capsules or blisters comprising the stabilized glycopyrronium salt (such as glycopyrronium bromide). The glycopyrronium salt (such as glycopyrronium bromide) or compositions of the invention may be used as a medicament, for instance in the treatment of asthma, chronic obstructive pulmonary disease or cystic fibrosis or related diseases.
    Type: Application
    Filed: July 25, 2017
    Publication date: June 13, 2019
    Inventors: Josep Terradas Camins, Josep Maria Carulla Oliver, Silvia Donnici Garcia, David Gomez Lamarca, Maria Jose Martinez Velon, Emma Recio Soler
  • Solid forms of dabigatran etexilate mesylate and processes for their preparation
    Patent number: 9073899
    Abstract: It relates to solid forms of dabigatran etexilate mesylate, in particular dabigatran etexilate mesylate in crystalline Form A, and in amorphous form; to processes for their preparation, and to pharmaceutical compositions comprising them. It also relates to a crystalline form of dabigatran etexilate base (Form A), and to a process for its preparation.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: July 7, 2015
    Assignee: ESTEVE QUÍMICA, S.A.
    Inventors: Martí Bartra Sanmartí, Rosa Maria Espinosa Ferrer, Maria del Pilar Lupon Roses, Stephen Benedict David Winter, Silvia Donnici Garcia
  • SOLID FORMS OF DABIGATRAN ETEXILATE MESYLATE AND PROCESSES FOR THEIR PREPARATION
    Publication number: 20150038721
    Abstract: It relates to solid forms of dabigatran etexilate mesylate, in particular dabigatran etexilate mesylate in crystalline Form A, and in amorphous form; to processes for their preparation, and to pharmaceutical compositions comprising them. It also relates to a crystalline form of dabigatran etexilate base (Form A), and to a process for its preparation.
    Type: Application
    Filed: February 21, 2013
    Publication date: February 5, 2015
    Inventors: Martí Bartra Sanmartí, Rosa Maria Espinosa Ferrer, Maria del Pilar Lupon Roses, Stephen Benedict David Winter, Silvia Donnici Garcia